Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics. (May 2015)
- Record Type:
- Journal Article
- Title:
- Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics. (May 2015)
- Main Title:
- Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics
- Authors:
- Voss, Erica A.
Ryan, Patrick B.
Stang, Paul E.
Hough, David
Alphs, Larry - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <p>This report examines relapse risk following a switch from risperidone long-acting injectable (RLAI) to another long-acting injectable antipsychotic [paliperidone palmitate (PP)] versus a switch to oral antipsychotics (APs). Truven Health's MarketScan Multistate Medicaid Database compared relapses following switches from RLAI. New user cohorts for these two groups were created on the basis of first incidence of exposure to the 'switched to' drug. Groups were balanced using 1:1 propensity score matching. Time-to-event analysis assessed schizophrenia-related hospital/emergency department visits. A total of 188 patients switched from RLAI to PP, and 131 patients switched from RLAI to oral AP. Propensity score-matched cohort included 109 patients who switched to PP and 109 patients who switched to an oral AP. Patients who switched from RLAI to PP had fewer events (26 vs. 32), longer time to an event (mean 70 vs. 47 days), and lower risk of relapse (hazard ratio, 0.54; 95% confidence interval, 0.32–0.92; <italic>P</italic>=0.024) compared with those who switched from RLAI to oral AP. Switching from RLAI to PP may be associated with a lower risk for relapse and longer duration of therapy compared with switching to oral AP. Given the limitations of observational studies, these results should be confirmed by other prospective evaluations.</p> </sec> </abstract>
- Is Part Of:
- International clinical psychopharmacology. Volume 30:Number 3(2015:May)
- Journal:
- International clinical psychopharmacology
- Issue:
- Volume 30:Number 3(2015:May)
- Issue Display:
- Volume 30, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 30
- Issue:
- 3
- Issue Sort Value:
- 2015-0030-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-05
- Subjects:
- Psychopharmacology -- Periodicals
Psychotropic drugs -- Periodicals
Psychopharmacology -- periodicals
Psychotropic Drugs -- periodicals
615.7805 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00004850-000000000-00000 ↗
http://www.intclinpsychopharm.com/ ↗
http://journals.lww.com/intclinpsychopharm/Pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://firstsearch.oclc.org ↗
http://www.lww.com/Product/0268-1315 ↗ - DOI:
- 10.1097/YIC.0000000000000068 ↗
- Languages:
- English
- ISSNs:
- 0268-1315
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4538.674500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4135.xml